Careium AB (CARE) AI Stock Analysis

• Market Cap: kr642.21M
• Dividend Yield: N/A
• Average Volume (3M): 14.72K
• Price to Earnings (P/E): 15.2
• Beta (1Y): 0.44
• Revenue Growth: 1.30%
• EPS Growth: -2.54%
• Country: SE
• Employees: 548
• Sector: Healthcare
• Sector Strength: 45
• Industry: Security & Protection Services
• EPS (TTM): 0.35
• Shares Outstanding: 24,326,214
• 10 Day Avg. Volume: 10,828
• 30 Day Avg. Volume: 14,717
• PEG Ratio: 0.23
• Price to Book (P/B): 1.09
• Price to Sales (P/S): 0.85
• P/FCF Ratio: 19.98
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: kr29.00 ▲(7.81% Upside)

Careium AB's overall stock score is driven by strong financial performance and positive technical indicators. The company's stable growth trajectory and solid balance sheet are complemented by bullish market momentum. While the valuation is reasonable, the lack of a dividend yield may limit appeal to some investors. The absence of earnings call and corporate events data did not impact the score.

Positive Factors

Strong Profitability

High profitability margins indicate efficient cost management and operational efficiency, which are crucial for long-term sustainability and competitiveness.

Stable Financial Position

A strong balance sheet with moderate leverage enhances financial stability and provides flexibility for future investments and growth opportunities.

Cash Flow Growth

Positive cash flow growth indicates improving cash generation, which supports reinvestment in the business and enhances financial resilience over time.

Negative Factors

Decline in Revenue Growth

A decline in revenue growth can signal challenges in market expansion or product adoption, potentially impacting long-term growth prospects and market position.

Revenue Growth Concerns

Sustained revenue growth is critical for maintaining competitive advantage and market leadership; a decline may hinder strategic initiatives and innovation.

Cash Conversion Efficiency

Weak cash conversion efficiency may limit the company's ability to fund operations and growth initiatives internally, affecting financial health and strategic flexibility.

Careium AB Business Overview & Revenue Model

Company Description

Careium AB (CARE) is a leading provider of innovative technology solutions in the health and care sector, focusing on enhancing the quality of life for elderly and vulnerable individuals. The company specializes in remote monitoring systems, digital healthcare services, and assistive technologies that enable efficient care delivery and improve patient outcomes. Careium operates primarily in the healthcare and technology sectors, offering a range of products that include telehealth platforms, wearable health devices, and integrated care solutions designed to support both individuals and healthcare providers.

How the Company Makes Money

Careium AB generates revenue through several key streams, including the sale and subscription of its digital health solutions and monitoring services. The company typically charges healthcare providers, municipalities, and private care organizations for access to its platforms and services, which can include one-time fees for hardware and ongoing subscription fees for software and support. Additionally, Careium may engage in partnerships with healthcare institutions and technology firms, enhancing its service offerings and expanding its market reach. These collaborations can lead to joint ventures, shared revenue opportunities, and increased visibility in the growing digital health market, thereby contributing to its overall earnings.

Careium AB Financial Statement Overview

Summary

Careium AB presents a stable financial profile with strong profitability and a solid balance sheet. Despite a recent decline in revenue growth, the company maintains healthy margins and moderate leverage. Cash flow generation is stable, though there is room for improving cash conversion efficiency.

Income Statement

Careium AB's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate by 3.15%, suggesting a potential slowdown in sales. However, the company maintains a healthy gross profit margin of 43.79% and a net profit margin of 5.30%, indicating efficient cost management and profitability. The EBIT and EBITDA margins are also solid at 8.46% and 16.59%, respectively, reflecting operational efficiency. Despite the recent revenue decline, the company has shown resilience in maintaining strong profitability metrics.

Balance Sheet

The balance sheet of Careium AB reflects a stable financial position with a debt-to-equity ratio of 0.31, indicating moderate leverage and a strong equity base. The return on equity (ROE) stands at 6.69%, which, while positive, suggests room for improvement in generating returns for shareholders. The equity ratio is robust, highlighting a solid capital structure with a significant portion of assets financed by equity. Overall, the balance sheet demonstrates financial stability, though there is potential for enhancing shareholder returns.

Cash Flow

Careium AB's cash flow analysis reveals a mixed picture. The free cash flow growth rate is positive at 2.11%, indicating an improvement in cash generation. However, the operating cash flow to net income ratio of 0.57 suggests that cash generation from operations could be stronger. The free cash flow to net income ratio of 0.27 indicates that a portion of earnings is being converted into free cash flow, but there is room for improvement. Overall, the cash flow position is stable, but enhancing cash conversion efficiency would be beneficial.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	852.10M	870.70M	824.60M	725.10M	587.50M	524.10M
Gross Profit	376.00M	373.70M	340.50M	273.70M	240.30M	217.30M
EBITDA	142.00M	150.60M	137.90M	67.90M	65.10M	71.50M
Net Income	42.20M	58.40M	37.90M	-8.60M	4.70M	18.80M
Balance Sheet
Total Assets	1.07B	1.05B	961.40M	992.10M	1.05B	717.30M
Cash, Cash Equivalents and Short-Term Investments	28.10M	31.90M	31.50M	39.90M	142.50M	32.20M
Total Debt	211.50M	196.80M	225.30M	322.70M	292.30M	156.70M
Total Liabilities	393.10M	371.40M	361.90M	425.50M	500.20M	330.80M
Stockholders Equity	677.50M	678.20M	599.50M	566.60M	551.50M	386.50M
Cash Flow
Free Cash Flow	42.70M	36.90M	61.90M	-87.10M	-70.90M	2.70M
Operating Cash Flow	109.20M	92.90M	111.90M	-21.10M	-19.80M	43.80M
Investing Cash Flow	-81.90M	-56.00M	-50.00M	-68.70M	-163.70M	-79.30M
Financing Cash Flow	-24.00M	-39.60M	-69.70M	-15.10M	291.00M	18.60M

Careium AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 26.90
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CARE, the sentiment is Positive. The current price of 26.9 is above the 20-day moving average (MA) of 25.67, above the 50-day MA of 24.91, and below the 200-day MA of 28.32, indicating a neutral trend. The MACD of 0.29 indicates Negative momentum. The RSI at 60.41 is Neutral, neither overbought nor oversold. The STOCH value of 75.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CARE.

Careium AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FIRE	78 Outperform	kr1.19B	27.40	―	2.86%	-3.93%	-7.54%
CARE	71 Outperform	kr642.21M	15.22	―	―	1.30%	-2.54%
CNCJO.B	57 Neutral	kr490.14M	19.79	4.07%	16.63%	-1.76%	59.61%
LEVEL	54 Neutral	€115.60M	-10.30	-1.58%	―	2.70%	85.94%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
IRIS	45 Neutral	€61.47M	―	-44.40%	―	-41.32%	34.95%
TSEC	44 Neutral	kr109.03M	-1.74	―	―	9.39%	-378.80%